Are you Dr. King?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 35 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1260 South Main Street Suite 202
Salinas, CA 93901Phone+1 831-769-9355Fax+1 831-754-4955- Is this information wrong?
Summary
- Dr. Allen King, MD is an endocrinologist in Salinas, California. He is currently licensed to practice medicine in California. He is affiliated with Salinas Valley Health and Community Hospital of the Monterey Peninsula.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1972 - 1974
University of ColoradoResidency, Internal Medicine, 1968 - 1969
Creighton University School of Medicine (Omaha)Internship, Internal Medicine, 1967 - 1968- Creighton University School of MedicineClass of 1967
Certifications & Licensure
CA State Medical License 1971 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes Start of enrollment: 2006 Oct 01
- The Effect of Pramlintide on Meal Time Insulin Bolus Start of enrollment: 2007 Sep 01
- Diabetes Mellitus Type 2 Basal Insulin Dosing Requirements Study Start of enrollment: 2009 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Excessive Basal Insulin Dosage When Following the Accepted Titration Method.Allen B. King> ;Endocrine Practice. 2021 Mar 8
- 2 citationsMean basal insulin dose is 0.2 U/kg/d at near normal glycaemia for type 1 or 2 diabetes on continuous subcutaneous insulin infusion or once-nightly basal insulinAllen B. King> ;Diabetes, Obesity & Metabolism. 2021 Mar 1
- 18 citationsA Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucos...Allen B. King, Athena Philis-Tsimikas, Eric S. Kilpatrick, Irene H. Langbakke, Kamilla Begtrup, Tina Vilsbøll> ;Diabetes Technology & Therapeutics. 2017 Apr 1
- Join now to see all
Press Mentions
Camp Mni Luzahan Launches Community Covid-19 TestingNovember 23rd, 2020
Professional Memberships
- Fellow
Hospital Affiliations
Salinas Valley HealthSalinas, California- Community Hospital of the Monterey PeninsulaMonterey, California
